Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Eisenhaur Patty
 2. Date of Event Requiring Statement (Month/Day/Year)
05/15/2009		 3. Issuer Name and Ticker or Trading Symbol
WATSON PHARMACEUTICALS INC [WPI]
(Last)
(First)
(Middle)
311 BONNIE CIRCLE		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
VP, Investor Relations
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

CORONA, CA 92880		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, par value $0.0033 5,232 (1)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy)   (2) 08/27/2011 Common Stock 4,701 $ 58.78 D  
Employee Stock Option (right to buy)   (3) 11/26/2011 Common Stock 4,392 $ 28.15 D  
Employee Stock Option (right to buy)   (4) 11/26/2011 Common Stock 1,608 $ 28.15 D  
Employee Stock Option (right to buy)   (5) 08/04/2013 Common Stock 2,000 $ 38.92 D  
Employee Stock Option (right to buy) 08/04/2004(6) 08/04/2013 Common Stock 500 $ 38.92 D  
Stock Option (right to buy)   (7) 08/12/2014 Common Stock 2,000 $ 27.26 D  
Employee Stock Option (right to buy)   (8) 08/12/2015 Common Stock 1,168 $ 35.11 D  
Employee Stock Option (right to buy) 08/12/2006(6) 08/12/2015 Common Stock 82 $ 35.11 D  
Employee Stock Option (right to buy) 12/15/2005(6) 08/27/2011 Common Stock 299 $ 58.78 D  
Employee Stock Option (right to buy) 08/12/2005(6) 08/12/2014 Common Stock 500 $ 27.26 D  
Employee Stock Option (right to buy)   (9) 09/01/2016 Common Stock 1,250 $ 25.64 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Eisenhaur Patty
311 BONNIE CIRCLE
CORONA, CA 92880		       VP, Investor Relations  

Signatures

PATRICIA L EISENHAUR 05/15/2009
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes shares of restricted stock issued pursuant to the Second Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.
(2) The option is exercisable in five (5) installments as follows: 1,000 options on 8/27/2002; 1,000 options on 8/27/2003; 1,000 options on 8/27/2004; 1,000 options on 8/27/2005; and 701 options on 12/15/2005. All options are vested.
(3) The option is exercisable in three (3) equal annual installments as follows: 1,464 options on 11/26/2002; 1,464 options on 11/26/2003; and 1,464 options on 11/26/2004. All options are vested.
(4) The option is exercisable in three (3) equal annual installments as follows: 536 options on 11/26/02; 536 options on 11/26/2003; and 536 options on 11/26/2004. All options are vested.
(5) The option is exercisable in two (2) installments as follows: 500 options on 8/4/2005; and 1,500 options on 12/15/2005. All options are vested.
(6) All options are vested.
(7) The option is exercisable in four (4) equal annual installments as follows: 500 options on 8/12/2006; 500 options on 8/12/2007; 500 options on 8/12/2008; and 500 options on 8/12/2009.
(8) The option is exercisable in four (4) installments as follows: 231 options on 8/12/2006; 313 options on 8/12/2007; 312 options on 8/12/2008; and 312 options on 8/12/2009.
(9) The option is exercisable in four installments as follows: 313 options on 9/1/2007; 313 options on 9/1/2008; 312 options on 9/1/2009; and 312 options on 9/1/2010.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.